Quinn Opportunity Partners LLC Pro Phase Labs, Inc. Transaction History
Quinn Opportunity Partners LLC
- $1.08 Billion
- Q2 2025
A detailed history of Quinn Opportunity Partners LLC transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, Quinn Opportunity Partners LLC holds 218,127 shares of PRPH stock, worth $95,975. This represents 0.01% of its overall portfolio holdings.
Number of Shares
218,127
Previous 318,127
31.43%
Holding current value
$95,975
Previous $127,000
33.07%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding PRPH
# of Institutions
34Shares Held
2.68MCall Options Held
12.3KPut Options Held
0-
Sykon Capital LLC Harrison, NY645KShares$283,7090.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA408KShares$179,6370.0% of portfolio
-
Geode Capital Management, LLC Boston, MA259KShares$113,9870.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL229KShares$100,9590.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny138KShares$60,6860.0% of portfolio
About ProPhase Labs, Inc.
- Ticker PRPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 16,024,400
- Market Cap $7.05M
- Description
- ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...